Skip to main content
. 2011 Mar 30;52(4):2065–2085. doi: 10.1167/iovs.10-6997h

Table 3.

Clinical Characteristics and Symptoms Assessed as Either Entry Criteria or Outcomes

Ref. First Author Evidence Level Title Clinical Testing Described/Performed Symptoms Transillumination (Obstruction and Dropout) MG Obstruction MG Secretions Interferometry Eyelid Temperature Lid Debris Lid Edema/Thickening Irregular Lid Lid Hyperemia/Erythema Lid Telangiectasia Conjunctival Papillae/Hyperemia TFBUT Corneal Staining Schirmer's Test Contact Lens Wear Acne Rosacea
17 Perry HD I Efficacy of commercially available topical cyclosporine A 0.05% in the treatment of meibomian gland dysfunction Yes Yes Yes (plugging) Yes Yes Yes Yes
21 Schechter BA I Efficacy of topical cyclosporine for the treatment of ocular rosacea Yes Yes Yes Yes Yes Yes Yes Yes
26 Yoo SE I The effect of low-dose doxycycline therapy in chronic meibomian gland dysfunction Yes Yes Yes Yes
8 Goto E I–II Low-concentration homogenized castor oil eye drops for noninflamed obstructive meibomian gland dysfunction Yes Yes Yes Yes Yes Yes Yes Yes Yes
20 Rubin M I–II Efficacy of topical cyclosporin 0.05% in the treatment of posterior blepharitis Yes Yes Yes Yes Yes Yes Yes
10 Luchs J II Efficacy of topical azithromycin ophthalmic solution 1% in the treatment of posterior blepharitis. Yes Yes Yes Yes Yes Yes Yes
12 Matsumoto Y II The evaluation of the treatment response in obstructive meibomian gland disease by in vivo laser confocal microscopy Yes Yes Yes Yes Yes Yes Yes
15 Olson MC II Increase in tear film lipid layer thickness following treatment with warm compresses in patients with meibomian gland dysfunction Yes Yes Yes Yes Yes Yes
16 Paugh JR II Meibomian therapy in problematic contact lens wear Yes Yes Yes Yes Yes Yes
18 Pinna A II Effect of oral linoleic and gamma-linolenic acid on meibomian gland dysfunction Yes Yes Yes Yes Yes Yes Yes Yes Yes
19 Romero JM II Conservative treatment of meibomian gland dysfunction Yes Yes Yes Yes Yes Yes Yes Yes Yes
24 Souchier M II Changes in meibomian fatty acids and clinical signs in patients with meibomian gland dysfunction after minocycline treatment Yes Yes Yes Yes Yes Yes Yes
25 Yalcin E II N-acetylcysteine in chronic blepharitis Yes Yes Yes
14 Mori A II–III Disposable eyelid-warming device for the treatment of meibomian gland dysfunction Yes Yes Yes Yes Yes
1 Albietz JM III Effect of antibacterial honey on the ocular flora in tear deficiency and meibomian gland disease Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes
2 Blackie CA III Inner eyelid surface temperature as a function of warm compress methodology Yes
3 Cetinkaya A III Pediatric ocular acne rosacea: long-term treatment with systemic antibiotics Yes Yes Yes Yes Yes Yes
4 Dougherty JM III The role of tetracycline in chronic blepharitis. Inhibition of lipase production in staphylococci No
5 Epstein GA III Combined excision and drainage with intralesional corticosteroid injection in the treatment of chronic chalazia
6 Goto E III Improvement of tear stability following warm compression in patients with meibomian gland dysfunction Yes Yes Yes Yes Yes Yes Yes
7 Goto E III Treatment of non-inflamed obstructive meibomian gland dysfunction by an infrared warm compression device Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes
9 Ishida R III Tear film with “Orgahexa EyeMasks” in patients with meibomian gland dysfunction Yes Yes Yes Yes Yes Yes Yes
11 Matsumoto Y III Efficacy of a new warm moist air device on tear functions of patients with simple meibomian gland dysfunction Yes Yes Yes Yes Yes Yes Yes
13 Meisler DM III Oral erythromycin treatment for childhood blepharokeratitis Yes Yes Yes Yes
22 Shine WE III Minocycline effect on meibomian gland lipids in meibomianitis patients Yes Yes Yes
23 Song CH III Enhanced secretory group II PLA2 activity in the tears of chronic blepharitis patients No
Total (n) 24 13 8 12 14 5 3 1 7 4 7 6 3 14 15 11 2 3
% (of 26) 92.3% 50.0% 30.8% 46.2% 53.8% 19.2% 11.5% 3.8% 26.9% 14.4% 26.9% 23.1% 11.5% 53.8% 57.7% 42.3% 7.7% 11.5%